DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Intron A (Interferon Alfa-2B) - Chills - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Chills (12)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Intron A (Interferon Alfa-2B) where reactions include chills. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Intron A side effects in

Reported by a pharmacist from United States on 2012-08-10

Patient:

Reactions: Chills, Tremor

Drug(s) suspected as cause:
Intron A



Possible Intron A side effects in male

Reported by a physician from United States on 2012-07-31

Patient: male, weighing 112.0 kg (246.4 pounds)

Reactions: Weight Decreased, Abdominal Pain, Nausea, Chills, Dysstasia, Fatigue, Diarrhoea, Dehydration, Dizziness, Fluid Intake Reduced

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A



Possible Intron A side effects in male

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-06-22

Patient: male

Reactions: Nausea, Chills, Pain, Radiation Skin Injury, Pyrexia, Treatment Noncompliance, Rash Pruritic, Fatigue, Lymph Node Pain, Liver Function Test Abnormal, Swelling, Asthenia, Lymphoedema, Post Procedural Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A (Interferon Alfa-2B)
    Dosage: 40 miu;;iv, 30 miu,,iv,
    Indication: Malignant Melanoma
    Start date: 2011-11-17
    End date: 2011-12-02

Intron A (Interferon Alfa-2B)
    Dosage: 40 miu;;iv, 30 miu,,iv,
    Indication: Malignant Melanoma
    Start date: 2011-11-07

Intron A
    Dosage: 20 miu; unk;, 15 miu;tiw;, 10 miu;tiw, 10 miu,tiw;
    Indication: Malignant Melanoma
    Start date: 2012-01-13
    End date: 2012-01-25

Intron A
    Dosage: 20 miu; unk;, 15 miu;tiw;, 10 miu;tiw, 10 miu,tiw;
    Indication: Malignant Melanoma
    Start date: 2012-02-13

Intron A
    Dosage: 20 miu; unk;, 15 miu;tiw;, 10 miu;tiw, 10 miu,tiw;
    Indication: Malignant Melanoma
    Start date: 2011-12-05

Other drugs received by patient: Levothyroxine Sodium



Possible Intron A side effects in female

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-05-23

Patient: female

Reactions: Renal Function Test Abnormal, Food Poisoning, Pain, Chills, Blood Count Abnormal, Headache, Pyrexia, Lower Respiratory Tract Infection, Fatigue, Liver Function Test Abnormal, Feeling of Body Temperature Change, Blood Pressure Abnormal, Blood Creatinine Increased, Lethargy, Blood Test Abnormal, Salmonella Sepsis, Dyspnoea, Cardiac Flutter, Nausea, Rash

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A
    Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
    Indication: Malignant Melanoma
    Start date: 2011-10-06
    End date: 2011-12-01

Intron A
    Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
    Indication: Malignant Melanoma
    Start date: 2012-01-16

Intron A
    Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
    Indication: Malignant Melanoma
    Start date: 2011-08-29

Intron A
    Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
    Indication: Malignant Melanoma
    Start date: 2011-10-03

Intron A
    Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
    Indication: Malignant Melanoma
    Start date: 2011-10-16

Intron A
    Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
    Indication: Malignant Melanoma
    Start date: 2012-05-07

Other drugs received by patient: Micardis; Amlodipine Besylate; Amlodipine Besylate; Atiacid; Zofran; Acetaminophen



Possible Intron A side effects in male

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-05-17

Patient: male

Reactions: Nausea, Pain, Chills, Pyrexia, Thermal Burn, Rash Pruritic, Hepatic Enzyme Increased, Asthenia, Lymphoedema, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A
    Dosage: 40 miu; iv, 30 miu; iv, 20 miu, 15 miu;tiw, 10 miu; tiw, 10 miu;tiw
    Indication: Malignant Melanoma
    Start date: 2011-11-07

Intron A
    Dosage: 40 miu; iv, 30 miu; iv, 20 miu, 15 miu;tiw, 10 miu; tiw, 10 miu;tiw
    Indication: Malignant Melanoma
    Start date: 2011-11-17
    End date: 2011-12-02

Intron A
    Dosage: 40 miu; iv, 30 miu; iv, 20 miu, 15 miu;tiw, 10 miu; tiw, 10 miu;tiw
    Indication: Malignant Melanoma
    Start date: 2011-12-05

Intron A
    Dosage: 40 miu; iv, 30 miu; iv, 20 miu, 15 miu;tiw, 10 miu; tiw, 10 miu;tiw
    Indication: Malignant Melanoma
    Start date: 2012-02-13

Intron A
    Dosage: 40 miu; iv, 30 miu; iv, 20 miu, 15 miu;tiw, 10 miu; tiw, 10 miu;tiw
    Indication: Malignant Melanoma
    Start date: 2012-01-13
    End date: 2012-01-25

Other drugs received by patient: Levothyroxine Sodium



Possible Intron A side effects in female

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-04-12

Patient: female

Reactions: Salmonella Sepsis, Dyspnoea, Cardiac Flutter, Renal Function Test Abnormal, Nausea, Chills, Food Poisoning, Headache, Rash, Lower Respiratory Tract Infection, Laboratory Test Abnormal, Fatigue, Liver Function Test Abnormal, White Blood Cell Count Increased, Lethargy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A
    Dosage: 40 miu; iv, 30 miu; iv, 22.6 miu; tiw; iv, 22.6 miu; tiw, 22.6 miu; tiw
    Indication: Malignant Melanoma
    Start date: 2011-10-03

Intron A
    Dosage: 40 miu; iv, 30 miu; iv, 22.6 miu; tiw; iv, 22.6 miu; tiw, 22.6 miu; tiw
    Indication: Malignant Melanoma
    Start date: 2011-10-16

Intron A
    Dosage: 40 miu; iv, 30 miu; iv, 22.6 miu; tiw; iv, 22.6 miu; tiw, 22.6 miu; tiw
    Indication: Malignant Melanoma
    Start date: 2012-01-16

Intron A
    Dosage: 40 miu; iv, 30 miu; iv, 22.6 miu; tiw; iv, 22.6 miu; tiw, 22.6 miu; tiw
    Indication: Malignant Melanoma
    Start date: 2011-08-29

Intron A
    Dosage: 40 miu; iv, 30 miu; iv, 22.6 miu; tiw; iv, 22.6 miu; tiw, 22.6 miu; tiw
    Indication: Malignant Melanoma
    Start date: 2011-10-06
    End date: 2011-12-01

Other drugs received by patient: Micardis; Antiacid; Zofran; Acetaminophen



Possible Intron A side effects in male

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-03-02

Patient: male

Reactions: Nausea, Pain, Chills, Radiation Skin Injury, Pyrexia, Thermal Burn, Rash Pruritic, Fatigue, Liver Function Test Abnormal, Asthenia, Post Procedural Infection, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A
    Dosage: 40 miu;iv, 30 miu;iv, 20 miu;unk, 15 miu;tiw, 10 miu;tiw
    Indication: Malignant Melanoma
    Start date: 2012-02-13

Intron A
    Dosage: 40 miu;iv, 30 miu;iv, 20 miu;unk, 15 miu;tiw, 10 miu;tiw
    Indication: Malignant Melanoma
    Start date: 2011-11-07

Intron A
    Dosage: 40 miu;iv, 30 miu;iv, 20 miu;unk, 15 miu;tiw, 10 miu;tiw
    Indication: Malignant Melanoma
    Start date: 2012-01-13
    End date: 2012-01-25

Intron A
    Dosage: 40 miu;iv, 30 miu;iv, 20 miu;unk, 15 miu;tiw, 10 miu;tiw
    Indication: Malignant Melanoma
    Start date: 2011-11-17
    End date: 2011-12-02

Intron A
    Dosage: 40 miu;iv, 30 miu;iv, 20 miu;unk, 15 miu;tiw, 10 miu;tiw
    Indication: Malignant Melanoma
    Start date: 2011-12-05

Other drugs received by patient: Levothyroxine Sodium



Possible Intron A side effects in female

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-02-07

Patient: female

Reactions: Dyspnoea, Cardiac Flutter, Nausea, Body Temperature Increased, Chills, Headache, Rash, Lower Respiratory Tract Infection, Fatigue, Liver Function Test Abnormal, Lethargy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A
    Dosage: 40 miu; ;iv 30 miu; ;iv 22.6 miu; ;tiw;iv; 22.6 miu;tiw ; 22.6 miu;tiw
    Indication: Malignant Melanoma
    Start date: 2011-10-16

Intron A
    Dosage: 40 miu; ;iv 30 miu; ;iv 22.6 miu; ;tiw;iv; 22.6 miu;tiw ; 22.6 miu;tiw
    Indication: Malignant Melanoma
    Start date: 2011-10-06
    End date: 2011-12-01

Intron A
    Dosage: 40 miu; ;iv 30 miu; ;iv 22.6 miu; ;tiw;iv; 22.6 miu;tiw ; 22.6 miu;tiw
    Indication: Malignant Melanoma
    Start date: 2012-01-16

Intron A
    Dosage: 40 miu; ;iv 30 miu; ;iv 22.6 miu; ;tiw;iv; 22.6 miu;tiw ; 22.6 miu;tiw
    Indication: Malignant Melanoma
    Start date: 2011-10-03

Intron A
    Dosage: 40 miu; ;iv 30 miu; ;iv 22.6 miu; ;tiw;iv; 22.6 miu;tiw ; 22.6 miu;tiw
    Indication: Malignant Melanoma
    Start date: 2011-08-29

Other drugs received by patient: Micardis; Zofran; Antiacid; Acetaminophen



Possible Intron A side effects in female

Reported by a health professional (non-physician/pharmacist) from Australia on 2011-12-19

Patient: female

Reactions: Dyspnoea, Cardiac Flutter, Nausea, Chills, Headache, Rash, Fatigue, Liver Function Test Abnormal, Lethargy

Drug(s) suspected as cause:
Intron A
    Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv
    Indication: Malignant Melanoma
    Start date: 2011-10-16

Intron A
    Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv
    Indication: Malignant Melanoma
    Start date: 2011-08-29

Intron A
    Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv
    Indication: Malignant Melanoma
    Start date: 2011-10-06

Intron A
    Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv
    Indication: Malignant Melanoma
    Start date: 2011-10-03

Other drugs received by patient: Micardis; Zofran; Antacid; Acetaminophen



Possible Intron A side effects in 55 year old male

Reported by a physician from United States on 2011-11-03

Patient: 55 year old male, weighing 59.0 kg (129.7 pounds)

Reactions: Pneumonia, Dyspnoea, Vomiting, Nausea, Chills, Respiratory Distress, Constipation, Chronic Obstructive Pulmonary Disease, Dehydration, Platelet Count Decreased, Crepitations, Dizziness, Gait Disturbance, Asthenia, Blood Glucose Increased, Decreased Appetite, Cough

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Intron A
    Dosage: sc
    Indication: Hepatitis C
    Start date: 2011-01-10
    End date: 2011-03-14

Rebetol
    Dosage: 1000 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-01-10
    End date: 2011-04-04

Other drugs received by patient: Catapres-TTS-2; Diflucan; Humulin R / Novolin R; Sodium Chloride; Xanax; Sodium Chloride; Fentanyl / NS; Lantus; Solu-Medrol; Nitroglycerin; Prilosec; Heparin Lock-Flush; Sodium Chloride; Aldactone; Ultram; Doribax; Cordarone; Dextrose; Reglan; Atropine Sulfate; Glucagon; Sodium Chloride; Theophylline; Norvasc; Combivent; Versed; Acetaminophen; Acetaminophen; Tussionex; Albuterol; Heparin Sodium; Protonix; Combivent; Dextrose 50% IN Water



Possible Intron A side effects in female

Reported by a health professional (non-physician/pharmacist) from Australia on 2011-10-31

Patient: female

Reactions: Fatigue, Cardiac Flutter, Body Temperature Increased, Nausea, Chills, Liver Function Test Abnormal, Headache

Drug(s) suspected as cause:
Intron A
    Dosage: unk;unk
    Indication: Malignant Melanoma
    Start date: 2011-10-16

Intron A
    Dosage: 40 miu;unk;iv, 30 miu;unk;iv, 22.6 miu;tiw;iv
    Indication: Malignant Melanoma
    Start date: 2011-10-03

Intron A
    Dosage: 40 miu;unk;iv, 30 miu;unk;iv, 22.6 miu;tiw;iv
    Indication: Malignant Melanoma
    Start date: 2011-08-29

Other drugs received by patient: Zofran; Acetaminophen; Micardis; Antacid



Possible Intron A side effects in 51 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-04

Patient: 51 year old female

Reactions: Pancreatitis Acute, Chills, Hyperhidrosis, Pallor, Pancreatitis Necrotising, Glomerulonephritis, Obesity, Chest Pain, Gastrooesophageal Reflux Disease, Renal Failure Acute, Refusal of Treatment by Patient, Type 2 Diabetes Mellitus, Blood Triglycerides Decreased, Hyponatraemia, Haemodialysis, Heart Rate Decreased, Skin Neoplasm Excision, Hypertension, Sleep Apnoea Syndrome, Influenza Like Illness

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Intron A
    Dosage: iv; iv
    Indication: Malignant Melanoma Stage III
    Start date: 2011-03-28
    End date: 2011-04-01

Intron A
    Dosage: iv; iv
    Indication: Malignant Melanoma Stage III
    Start date: 2011-03-21
    End date: 2011-03-25

Decadron

Other drugs received by patient: Compazine; Hydrochlorothiazide; Aspirin; Percocet; Norvasc

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017